GlassScriptPhysician profile
Justin Burkhardt
NPI 1265904510
$1,144.94
in general payments reported to CMS, 2019-2025
15 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $521 · 2022: $82.63 · 2023: $164 · 2024: $249 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $508.42 | 2021-2024 | |
| Biogen, INC. | $234.19 | 2021-2022 | |
| Axsome Therapeutics, INC. | $87.56 | 2025 | Auvelity |
| Upsher-Smith Laboratories LLC | $66.83 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $59.80 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $25.41 | 2025 | Farxiga |
| Biohaven Pharmaceutical Holding Company LTD. | $23.63 | 2022 | |
| Lilly USA, LLC | $23.54 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $21.08 | 2024 | Rexulti |
| Janssen Pharmaceuticals, INC | $20.12 | 2021 | |
| Sunovion Pharmaceuticals INC. | $19.23 | 2021 | |
| Exact Sciences Corporation | $14.99 | 2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $14.08 | 2022 | |
| Grifols USA, LLC | $13.59 | 2021 | |
| Jazz Pharmaceuticals INC. | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Burkhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.